There are no Events available right now.
Contact
Jena
Prof. Dr. Ulrich S. Schubert
Friedrich Schiller University Jena
Humboldtstraße 10
07743 Jena
Bayreuth
Prof. Dr.-Ing. Holger Ruckdäschel
University of Bayreuth
Universitätsstraße 30
95447 Bayreuth
© 2023 Joint Lab for Polymers Jena-Bayreuth. All Rights Reserved
Bayreuth researcher develops high-performance digital system for tailoring polymers
Polymers have become an indispensable part of everyday life. However, the current polymers represent only a small fraction of the huge number of polymers that theoretically exist. Prof. Dr. Christopher Kuenneth at the University of Bayreuth, Germany, together with research partners in Atlanta, USA, have now developed a digital system that promises extraordinarily high economical, […]
A new perspective in protein research
The ordered areas of proteins are readily studied. Consequently, a great deal is known about the role of these areas in the biological function of the respective proteins. However, an international research team led by biochemist Prof. Dr Ute Hellmich has shown that disordered areas are also pivotal. Their comprehensive examination of the disordered area […]
A flagship of digitization: Opening ceremony for the FIM Research Institute for Information Management
The responsible institutions are the University of Bayreuth and the Technical University of Applied Sciences Augsburg: close cooperation in the future fields of digitization. A world in which digital innovations are used responsibly both for individuals and for the economy and society as a whole – this is the goal and mission statement of the […]
University of Bayreuth among the best young universities worldwide
The prestigious, international THE Young University Ranking of “Universities under 50” places the University of Bayreuth among the top 10 percent worldwide. This is further proof of its high academic reputation. THE Young University Ranking evaluates universities younger than 50 years in five categories: Teaching, Research, Impact of Research (citations), Internationality of Staff, Students and […]
SmartDyeLivery receives phase I clinical trial approval
The Federal Institute for Drugs and Medical Devices (BfArM) has approved SmartDyeLivery GmbH’s entry into the clinical phase after reviewing the content of the application. Thus, for the first time, nanotransporters that are being developed for a specific therapy of septic liver failure can be tested on healthy subjects in a clinical setting. More information